» Articles » PMID: 2203825

Vasoactive Intestinal Peptide in Human Nasal Mucosa

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1990 Sep 1
PMID 2203825
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Vasoactive intestinal peptide (VIP), which is present with acetylcholine in parasympathetic nerve fibers, may have important regulatory functions in mucous membranes. The potential roles for VIP in human nasal mucosa were studied using an integrated approach. The VIP content of human nasal mucosa was determined to be 2.84 +/- 0.47 pmol/g wet weight (n = 8) by RIA. VIP-immunoreactive nerve fibers were found to be most concentrated in submucosal glands adjacent to serous and mucous cells. 125I-VIP binding sites were located on submucosal glands, epithelial cells, and arterioles. In short-term explant culture, VIP stimulated lactoferrin release from serous cells but did not stimulate [3H]glucosamine-labeled respiratory glycoconjugate secretion. Methacholine was more potent than VIP, and methacholine stimulated both lactoferrin and respiratory glycoconjugate release. The addition of VIP plus methacholine to explants resulted in additive increases in lactoferrin release. Based upon the autoradiographic distribution of 125I-VIP binding sites and the effects on explants, VIP derived from parasympathetic nerve fibers may function in the regulation of serous cell secretion in human nasal mucosa. VIP may also participate in the regulation of vasomotor tone.

Citing Articles

The airway neuro-immune axis as a therapeutic target in allergic airway diseases.

Wu W, Li J, Chen S, Ouyang S Respir Res. 2024; 25(1):83.

PMID: 38331782 PMC: 10854139. DOI: 10.1186/s12931-024-02702-8.


spp. utilize the type 3 secretion system to manipulate the VIP/VPAC2 signaling and promote colonization and persistence of the three classical in the lower respiratory tract.

First N, Pedreira-Lopez J, San-Silvestre M, Parrish K, Lu X, Gestal M Front Cell Infect Microbiol. 2023; 13:1111502.

PMID: 37065208 PMC: 10090565. DOI: 10.3389/fcimb.2023.1111502.


Regulatory Peptides in Asthma.

Kaczynska K, Zajac D, Wojciechowski P, Jampolska M Int J Mol Sci. 2021; 22(24).

PMID: 34948451 PMC: 8707337. DOI: 10.3390/ijms222413656.


Neuropeptide Y Reduces Nasal Epithelial T2R Bitter Taste Receptor-Stimulated Nitric Oxide Production.

Carey R, Adappa N, Palmer J, Lee R Nutrients. 2021; 13(10).

PMID: 34684394 PMC: 8538228. DOI: 10.3390/nu13103392.


Standardizing salivary lactoferrin measurements to obtain a robust diagnostic biomarker for Alzheimer's disease.

Bartolome F, Orive G, Carro E Alzheimers Dement (Amst). 2021; 13(1):e12173.

PMID: 33969170 PMC: 8088590. DOI: 10.1002/dad2.12173.


References
1.
CAUNA N, HINDERER K . Fine structure of blood vessels of the human nasal respiratory mucosa. Ann Otol Rhinol Laryngol. 1969; 78(4):865-79. DOI: 10.1177/000348946907800418. View

2.
Ollerenshaw S, Jarvis D, Woolcock A, Sullivan C, Scheibner T . Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med. 1989; 320(19):1244-8. DOI: 10.1056/NEJM198905113201904. View

3.
MALM L, Sundler F, Uddman R . Effects of vasoactive intestinal polypeptide on resistance and capacitance vessels in the nasal mucosa. Acta Otolaryngol. 1980; 90(3-4):304-8. DOI: 10.3109/00016488009131730. View

4.
Coles S, Said S, Reid L . Inhibition by vasoactive intestinal peptide of glycoconjugate and lysozyme secretion by human airways in vitro. Am Rev Respir Dis. 1981; 124(5):531-6. DOI: 10.1164/arrd.1981.124.5.531. View

5.
Lundberg J, Anggard A, Fahrenkrug J . Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. II. Effects of cholinergic antagonists and VIP antiserum. Acta Physiol Scand. 1981; 113(3):329-36. DOI: 10.1111/j.1748-1716.1981.tb06903.x. View